Skip to main content
. 2021 May 17;12:2871. doi: 10.1038/s41467-021-23114-y

Table 3.

GMCs for IgG-PT, IgG-Dt and IgG-TT in IU/mL per country and by age group.

IgG-PT (IU/mL) IgG-Dt (IU/mL) IgG-TT (IU/mL)
Country Age group GMC (95% CI) p value GMC (95% CI) p value GMC (95% CI) p value
AT 40–49 11.8 (9.8–14.1) 0.08 (0.06–0.10) 1.84 (1.64–2.07)
50–59 7.8 (6.5–9.4) 0.05 (0.04–0.06) 1.85 (1.63–2.10)
Total 9.6 (8.4–10.9) 0.002 0.06 (0.06–0.07) 0.008 1.85 (1.70–2.01) 0.952
BE 40–49 12.1 (10.1–14.4) 0.07 (0.06–0.09) 1.64 (1.38–1.95)
50–59 12.4 (10.4–14.9) 0.04 (0.03–0.05) 1.34 (1.09–1.64)
Total 12.2 (10.8–13.9) 0.829 0.05 (0.05–0.06) <0.001 1.48 (1.30–1.69) 0.136
DK 40–49 10.8 (9.0–13.0) 0.08 (0.07–0.10) 1.80 (1.52–2.13)
50–59 13.3 (11.0–15.9) 0.08 (0.06–0.09) 2.02 (1.70–2.41)
Total 12.0 (10.5–13.6) 0.128 0.08 (0.07–0.09) 0.739 1.91 (1.69–2.15) 0.346
FI 40–49 7.4 (6.2–8.9) 0.29 (0.24–0.36) 3.23 (2.93–3.57)
50–59 8.0 (6.7–9.6) 0.22 (0.18–0.27) 3.10 (2.77–3.47)
Total 7.7 (6.8–8.8) 0.544 0.25 (0.22–0.29) 0.053 3.16 (2.94–3.41) 0.582
FR 40–49 12.9 (10.9–15.2) 0.27 (0.23–0.33) 1.94 (1.72–2.20)
50–59 14.0 (11.8–16.5) 0.09 (0.08–0.11) 1.28 (1.12–1.45)
Total 13.4 (11.9–15.1) 0.502 0.16 (0.14–0.18) <0.001 1.58 (1.44–1.73) <0.001
GR 40–49 8.0 (6.7–9.6) 0.03 (0.02–0.04) 0.62 (0.51–0.75)
50–59 7.6 (6.3–9.1) 0.01 (0.01–0.01) 0.21 (0.17–0.26)
Total 7.8 (6.9–8.9) 0.675 0.01 (0.01–0.02) <0.001 0.36 (0.31–0.42) <0.001
HU 40–49 7.5 (6.3–8.9) 0.08 (0.07–0.10) 2.38 (2.02–2.79)
50–59 8.2 (6.9–9.7) 0.05 (0.04–0.07) 2.24 (1.92–2.62)
Total 7.8 (6.9–8.8) 0.495 0.07 (0.06–0.08) 0.006 2.31 (2.06–2.58) 0.614
IE 40–49 10.7 (8.9–12.8) 0.02 (0.02–0.03) 0.79 (0.64–0.97)
50–59 12.2 (10.1–14.6) 0.02 (0.02–0.02) 0.64 (0.50–0.81)
Total 11.4 (10.0–12.9) 0.317 0.02 (0.02–0.02) 0.006 0.71 (0.60–0.83) 0.184
LV 40–49 7.0 (5.8–8.4) 0.26 (0.21–0.31) 1.94 (1.70–2.20)
50–59 11.1 (9.2–13.2) 0.11 (0.09–0.14) 1.42 (1.21–1.65)
Total 8.8 (7.7–10.0) <0.001 0.17 (0.15–0.20) <0.001 1.66 (1.50–1.83) 0.002
LT 40–49 10.6 (8.8–12.7) 0.17 (0.14–0.21) 1.29 (1.10–1.51)
50–59 15.0 (12.5–18.0) 0.08 (0.07–0.10) 1.03 (0.85–1.24)
Total 12.6 (11.1–14.3) 0.007 0.12 (0.10–0.13) <0.001 1.15 (1.02–1.30) 0.076
NL 40–49 9.7 (8.7–10.7) 0.06 (0.06–0.07) 1.24 (1.13–1.36)
50–59 11.2 (10.2–12.4) 0.06 (0.06–0.07) 1.20 (1.10–1.32)
Total 10.4 (9.7–11.2) 0.037 0.06 (0.06–0.07) 0.700 1.22 (1.14–1.30) 0.690
NO 40–49 13.0 (10.9–15.6) 0.17 (0.14–0.21) 1.45 (1.24–1.68)
50–59 16.9 (14.1–20.2) 0.16 (0.13–0.19) 1.18 (0.98–1.41)
Total 14.8 (13.1–16.9) 0.047 0.16 (0.14–0.19) 0.553 1.31 (1.16–1.47) 0.084
PT 40–49 6.9 (5.7–8.2) 0.12 (0.10–0.15) 2.63 (2.36–2.92)
50–59 8.8 (7.4–10.6) 0.11 (0.09–0.14) 2.63 (2.38–2.91)
Total 7.8 (6.8–8.8) 0.055 0.12 (0.10–0.14) 0.688 2.63 (2.44–2.83) 0.974
RO 40–49 9.9 (8.3–11.9) 0.03 (0.02–0.04) 0.80 (0.69–0.93)
50–59 10.9 (9.1–13.0) 0.03 (0.02–0.04) 0.56 (0.47–0.66)
Total 10.4 (9.1–11.8) 0.479 0.03 (0.03–0.03) 0.762 0.67 (0.60–0.75) 0.002
SK 40–49 9.5 (7.9–11.4) 0.06 (0.05–0.08) 1.56 (1.36–1.80)
50–59 8.2 (6.8–9.8) 0.05 (0.04–0.06) 1.64 (1.42–1.89)
Total 8.8 (7.8–10.0) 0.254 0.06 (0.05–0.07) 0.168 1.60 (1.45–1.77) 0.632
SI 40–49 10.4 (8.7–12.4) 0.18 (0.14–0.22) 2.03 (1.79–2.30)
50–59 8.6 (7.2–10.3) 0.12 (0.09–0.14) 2.01 (1.76–2.30)
Total 9.4 (8.3–10.7) 0.150 0.14 (0.12–0.17) 0.004 2.02 (1.85–2.21) 0.916
SE 40–49 11.6 (9.7–13.9) 0.07 (0.06–0.09) 1.14 (0.97–1.36)
50–59 9.4 (7.8–11.2) 0.05 (0.04–0.06) 1.22 (1.01–1.46)
Total 10.4 (9.2–11.8) 0.100 0.06 (0.05–0.07) 0.012 1.18 (1.04–1.34) 0.626
UK 40–49 7.3 (6.1–8.8) 0.03 (0.03–0.04) 0.86 (0.72–1.02)
50–59 7.2 (6.0–8.6) 0.02 (0.02–0.03) 0.80 (0.67–0.95)
Total 7.2 (6.4–8.2) 0.901 0.03 (0.02–0.03) 0.001 0.83 (0.73–0.93) 0.578

P values are given for the difference between the two age groups. Abbreviations of all participating countries and the number of samples included in the study are listed in Table 1.